Recalcitrant Dermatomyositis Treated With Anifrolumab
Dermatomyositis is an idiopathic inflammatory myopathy which can present with distinctive skin features. Despite the many treatment modalities for the treatment of dermatomyositis some patients remain refractory to treatment. We present a case of a 38‐year‐old man with recalcitrant dermatomyositis w...
Saved in:
| Main Authors: | Shivang Chaudhary, Meghan Baumer, Laura Upton, Samantha Ong, Kristin Smith, Daniel West, Adam Kilian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | ACR Open Rheumatology |
| Online Access: | https://doi.org/10.1002/acr2.11792 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anifrolumab in Refractory Dermatomyositis and Antisynthetase Syndrome
by: Ryan Bonaventure Soares, et al.
Published: (2025-01-01) -
Case of recalcitrant amyopathic dermatomyositis treated with upadacitinib
by: Albert E. Zhou, MD, PhD, et al.
Published: (2024-12-01) -
Successful treatment of recalcitrant cutaneous lupus erythematosus with anifrolumab in patients without systemic lupus erythematosus
by: Bishoy Abdelmalik, BS, et al.
Published: (2025-01-01) -
Adjunctive anifrolumab for recalcitrant discoid lupus erythematosus in the setting of systemic lupus erythematosus: A case report
by: Gabriela Soto-Canetti, MPH, et al.
Published: (2025-06-01) -
Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin
by: Megan E. McNamara, PhD, et al.
Published: (2025-08-01)